MCMaría-Jesús Citores

María-Jesús Citores

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


María-Jesús Citores has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic polymorphisms in endosomal Toll-like receptors and their association with susceptibility to and clinical course of systemic lupus erythematosus in a Spanish cohort

    by Elena Martínez-Robles, Susana Mellor-Pita, Pablo Tutor-Ureta, Laura Medina, Ana Huerta, Miguel Yebra-Bango, María J. Citores

  • Open Access

    Chronic kidney disease at one year after liver transplantation: Role of changes in immunosuppression over three decades

    by Alejandro Muñoz-Serrano, María Jesús Citores, Andrea Gutiérrez-Villanueva, Víctor Moreno-Torres, Jorge V López-Ibor, Natalia Vicente, Valentín Cuervas-Mons

    BACKGROUND Kidney disease is a common complication in liver transplant (LT) recipients, contributing to substantial morbidity and mortality. Calcineurin inhibitors are associated with short- and long-term decline in kidney function. AIM To assess how changes in immunosuppression over three decades have impacted the evolution of renal function in the first year post-LT. METHODS This single-center, observational, retrospective study was conducted in a tertiary hospital in Madrid. Adult patients who received a first LT in our center from 1987 to 2019 were included. Patients with simultaneous or prior transplantation of another organ and patients who required re-transplantation, or were lost to follow-up or died during the first year after transplantation were excluded. The development of chronic kidney disease (CKD) pre-transplant or at the first year after LT was analyzed. RESULTS A total of 594 patients (median age: 52.9 years, 25th-75th percentiles = 45-59.08 years; 29.3% female) were included. At 1 year post-transplant, 290 (48.82%) patients had developed CKD. Older age [odds ratio (OR) = 1.03, 95%CI: 1.01-1.05], female sex (OR = 1.88, 95%CI: 1.23-2.89), pre-transplant renal dysfunction (RD) (OR = 2.69, 95%CI: 1.58-4.58), and treatment with cyclosporine A (CsA) (OR = 3.77, 95%CI: 2.45-5.78) were independent risk factors for CKD at 1 year after LT. In patients treated with tacrolimus (Tac) (n = 375), the combination of basiliximab and mycophenolic acid (MPA) resulted in decreased Tac blood levels (P < 0.001); additionally, MPA was associated with a lower incidence of RD in the first year (P = 0.016). CONCLUSION Age, female sex, pre-transplant RD, and CsA are associated with increased risk of CKD within 1 year after LT. Addition of MPA to Tac is associated with lower RD incidence.


  • Open Access

    Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients

    by Maria J. Citores, Aranzazu Caballero-Marcos, Valentín Cuervas-Mons, Roberto Alonso-Fernández, Javier Graus-Morales, Ana Arias-Milla, Maricela Valerio, Patricia Muñoz, Magdalena Salcedo


  • Role of TGF-β1 +869T>C polymorphism in renal dysfunction one year after heart transplantation

    by Jorge V. López-Ibor, María J. Citores, Jose Portoles, Manuel Gómez-Bueno, Beatriz Sánchez-Sobrino, Alejandro Muñoz, Valentín Cuervas-Mons, Javier Segovia-Cubero


  • Effective definition of low humoral response to Clostridioides difficile infection

    by Antonio Ramos-Martínez, Francisco Serrano-Martínez, Ilduara Pintos, Ángela Valencia-Alijo, Ángela Gutiérrez-Rojas, María Jesús Cítores, Jorge Ortiz-Balbuena, Ana Royuela, Rocío Martínez-Ruiz, Isabel Sánchez-Romero, et al.


  • Open Access

    Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients

    by Maria Martinez-Urbistondo, Alberto Mora-Vargas, Esther Expósito-Palomo, Raquel Castejón, M. Jesús Citores, Silvia Rosado, Carmen de Mendoza, Isolina Baños, Ana Fernández-Cruz, Lidia Daimiel, et al.

    Background. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection elicits inflammatory manifestations that relate with a cytokine storm. Objective. The aim of this research was to assess the role of circulating interleukin 6 (IL-6) levels and other inflammatory markers in patients with coronavirus disease 2019 (COVID-19) on metabolic functions and accompanying clinical complications. Patients and Methods. A total of 165 patients diagnosed with COVID-19 pneumonia were examined for medical features and inflammatory markers such as blood IL-6, CRP, ferritin, LDH, neutrophil/lymphocyte index (NLI), D-Dimer, and Red Cell Distribution Width (RDW). Regression analyses concerning electronically collected medical data were adjusted by appropriate factors and confounding variables. Results. Plasma IL-6 determinations evidenced a consistent association with hospital stay days, Intensive Care Unit (ICU) admission, and mortality rates. Similar trends were found for other proinflammatory variables, where ferritin and NLI showed a remarkable value as surrogates. Hyperglycaemia and the Charlson Comorbidity Index Score were positively associated with the inflammatory response induced by the SARS-COV-2 infection. An unhealthy lifestyle such as smoking and alcoholic drinks consumption as well as excessive body adiposity influenced inflammatory-related outcomes in the screened patients. Conclusion. IL-6 together with other inflammatory biomarkers accompanied poor clinical and metabolic outcomes in COVID-19-infected patients. IL-6 may result in a suitable proxy to individually categorise patients in order to manage this infectious pandemic.


  • TLR9 -1486C/T Polymorphism Is Associated with Hepatocellular Carcinoma Recurrence After Liver Transplantation

    by Sara de la Fuente, María-Jesús Citores, José-Luis Lucena, Pablo Muñoz, Valentín Cuervas-Mons

    Aim: To determine whether TLR9 polymorphisms are associated with tumor recurrence after liver transplantation for hepatocellular carcinoma (HCC). Patients & methods: All patients who underwent liver transplantation, and had viable HCC in the explanted liver were included. TLR9-1237C/T and -1486C/T polymorphisms were analyzed by real-time PCR and melting curves analysis. Results: 20 of 159 patients (12.6%) developed post-transplant HCC recurrence. Tumors exceeding Milan criteria, moderately-to-poorly differentiated tumors and microvascular invasion on explants, and pretransplant alpha-fetoprotein level (all p < 0.01) were associated with an increased risk, while TLR9-1486TT genotype was associated with a decreased risk of HCC recurrence (p = 0.03). Conclusion: TLR9-1486C/T might help to preoperatively identify patients at low risk of post-transplant HCC recurrence.


  • Open Access

    Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation

    by Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons

    Liver transplantation (LT) is the only potentially curative treatment for selected patients with cirrhosis and hepatocellular carcinoma (HCC) who are not candidates for resection. When the Milan criteria are strictly applied, 75% to 85%of 3- to 4-year actuarial survival rates are achieved, but up to 20% of the patients experience HCC recurrence after transplantation. The Milan criteria are based on the preoperative tumor macromorphology, tumor size and number on computed tomography or magnetic resonance imaging that neither correlate well with posttransplant histological study of the liver explant nor accurately predict HCC recurrence after LT, since they do not include objective measures of tumor biology. Preoperative biological markers, including alpha-fetoprotein, des-gamma-carboxiprothrombin or neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio, can predict the risk for HCC recurrence after transplantation. These biomarkers have been proposed as surrogate markers of tumor differentiation and vascular invasion, with varied risk magnitudes depending on the defined cutoffs. Different studies have shown that the combination of one or several biomarkers integrated into prognostic models predict the risk of HCC recurrence after LT more accurately than Milan criteria alone. In this review, we focus on the potential utility of these serum biological markers to improve the performance of Milan criteria to identify patients at high risk of tumoral recurrence after LT.


  • Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism

    by Maria J. Citores, Sofia Pérez-Pulgar, Ana Duca, Gonzalo Crespo, Sara de la Fuente, Carlos Vilches, Miquel Navasa, Valentin Cuervas-Mons

    Liver transplantation activates the innate immune system through toll-like receptors (TLRs), potentially leading to allograft rejection and graft failure. We evaluated the association of single nucleotide polymorphisms in TLR genes with the severity of hepatitis C virus recurrence after liver transplantation (LT). This is a two-centre study of 176 adult patients who received a first LT from deceased donors for hepatitis C virus (HCV) cirrhosis. Eleven polymorphisms were evaluated by real-time polymerase chain reaction and melting curves analyses: TLR1 (Asp248Ser and Ser602Ile), TLR2 (Arg753Gln), TLR3 (Leu412Phe), TLR4 (Asp299Gly), TLR5 (Arg392Stop), TLR6 (Ser249Pro), TLR7 (Gln11Leu), TLR8 (Met1Val) and TLR9 (-1237T/C and -1486C/T). The CC genotype of TLR3 Leu412Phe in liver recipients was associated with severe recurrence (odds ratio (OR) =2.01, 95% confidence interval (95% CI) = 1.02-3.93, P=0.04). We also analyzed this polymorphism in 72 of their donors but no association was found with severity of HCV recurrence (p=0.89). Multivariate analysis showed donor age older than 40 years (OR=2.93; 95% CI =1.49-5.8, P= 0.002) and the TLR3 Leu412Phe CC genotype (OR=2.02, 95%CI=1.01-4.05, P=0.046) were independently associated with severe HCV recurrence. Our results show that the TLR3 Leu412Phe CC genotype is independently associated with severity of hepatitis C recurrence after LT. This article is protected by copyright. All rights reserved.